← SynDRA

ELRAGLUSIB

SynDRA canonical compound SYN0016556 — structure-anchored drug synonym record

All known targets

• GSK3B
• MARK2

Mechanisms of action (all sources)

• GSK3B INHIBITOR
• Glycogen synthase kinase-3 beta inhibitor

Cross-references

• PubChem CID: 44582816
• ChEMBL: CHEMBL483465
• DrugBank: DB16047
• KEGG: D12304
• TTD: D4USX5

Synonyms

• 9-ING-41
• ND1SOF0DLU
• UNII-ND1SOF0DLU
• CHEMBL483465
• 3-(5-fluoro-1-benzofuran-3-yl)-4-(5-methyl-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
• 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)-1H-pyrrole-2,5-dione
• SCHEMBL3152351
• GTPL11412
• EX-A4074
• BDBM50267716
• s9602
• SB19735
• compound 26 [PMID: 19338355]
• HY-113914
• CS-0063319
• 1H-Pyrrole-2,5-dione, 3-(5-fluoro-3-benzofuranyl)-4-(5-methyl-5H-1,3-dioxolo(4,5-F)indol-7-yl)-
• 3-(5-Fluoro-benzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-F)indol-7-yl)-pyrrole-2,5-dione
• 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
• 4-(5-methyl-5H-[1,3]dioxolo[4,5-f]-indol-7-yl)-3-(5-fluoro-1-benzofuran-3-yl)-1 h-pyrrole-2,5-dione
• 9 ing 41
• Elraglusib [USAN]
• ELRAGLUSIB [INN]
• Elraglusib (USAN)
• compound 26 (PMID: 19338355)
• RefChem:136552
• GSK-3 Inhibitor 9-ING-41
• Glycogen Synthase Kinase-3 Inhibitor 9-ING-41
• Elraglusib [WHO-DD]
• orb1308709
• SCHEMBL29379243
• SCHEMBL29687603
• C22H13FN2O5
• 9-ING-41?
• EBC-13375
• NSC853808
• WHO 11553
• AKOS040741011
• NSC-853808